While iRhom2 activity was already linked to squamous cell carcinoma of the esophagus in TOC patients, new evidence further links iRhom2 expression to oral squamous cell carcinomas [105]. This evidence concerns the gene RHBDF2 and oral cavity squamous cell carcinoma.